Allergic rhinitis and impairment issues in schoolchildren: a consensus report

Authors: Blaiss, Michael S.1; on behalf of the Allergic Rhinitis in Schoolchildren Consensus Group,

Source: Current Medical Research and Opinion, Volume 20, Number 12, December 2004 , pp. 1937-1952(16)

Publisher: Informa Healthcare

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Background: Allergic rhinitis (AR) can have a substantial negative impact on children. Most notably, it can impede learning during the schoolage years. Other consequences include adverse behavioral and psychosocial effects, poor quality of life, and potential impact on serious comorbidities, such as asthma.

Consensus panel: In February 2004, in a conference sponsored by Aventis Pharmaceuticals, a multidisciplinary group convened to review relevant clinical data for the purposes of developing consensus recommendations for the management of AR in children. The consensus panel consisted of academic, school health, and medical providers, who were identified based on previous work and publications.

Consensus findings: The focus of discussions was to assess the degree of impact of AR in schoolchildren and, based on this information, to determine how to improve screening, diagnosis, prevention, and treatment, to help ensure quality of life and maximal school performance in this population. The group considered the most critical factor in successful management to be communication and collaboration among parents, educators, and healthcare professionals. Knowledge of the common signs and symptoms of AR in children can help to ensure early diagnosis, appropriate intervention, and clinically favorable outcomes. Importantly, both uncontrolled symptoms of AR, as well as adverse effects from medications, can diminish cognitive function and learning. When choosing treatment for children with AR, consideration must be given to the side effects of medications. All first-generation and some second-generation antihistamines can be associated with adverse effects on cognitive function and learning, as a result of their sedative properties. Treatment with a non-sedating second-generation antihistamine has been shown to improve learning potential and is an ideal choice for treatment in this population.

Conclusion: Existing data indicate that further studies using objective measures of impairment in children taking antihistamine medications should be conducted to evaluate the impact of disease and treatment.

Keywords: ALLERGIC RHINITIS; ALLERGY MEDICATIONS; COGNITIVE FUNCTION; IMPAIRMENT; SCHOOL PERFORMANCE; SCHOOLCHILDREN; SEDATION

Document Type: Commentary

DOI: 10.1185/030079904X13266

Affiliations: 1: University of Tennessee Health Science Center, Germantown, TN, USA

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$51.50 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A